1,131 Shares in Waters Corporation $WAT Bought by Aprio Wealth Management LLC

Key Points

• Aprio Wealth Management LLC has invested approximately $417,000 in Waters Corporation, acquiring 1,131 shares of the medical instruments supplier in the first quarter.
• Analysts have set a consensus price target for Waters at $378.73, with ratings ranging from "Strong Buy" to "Hold".
• Waters Corporation reported earnings of $2.95 per share for the last quarter, surpassing analysts' estimates, alongside an 8.8% year-over-year revenue growth.

Aprio Wealth Management LLC purchased a new stake in Waters Corporation (NYSE:WAT - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,131 shares of the medical instruments supplier's stock, valued at approximately $417,000.

A number of other institutional investors have also modified their holdings of the company. Olde Wealth Management LLC purchased a new position in Waters during the 1st quarter worth approximately $25,000. Zions Bancorporation National Association UT purchased a new stake in shares of Waters during the first quarter worth $28,000. IFP Advisors Inc grew its holdings in shares of Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after buying an additional 44 shares in the last quarter. Whipplewood Advisors LLC grew its holdings in shares of Waters by 5,200.0% during the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after buying an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new position in shares of Waters during the 1st quarter valued at about $41,000. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

WAT has been the topic of several research reports. Wall Street Zen cut shares of Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a "buy" rating in a report on Monday, August 4th. UBS Group reaffirmed a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Scotiabank restated a "sector outperform" rating and issued a $465.00 price target on shares of Waters in a research report on Friday, July 11th. Finally, Wells Fargo & Company dropped their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $378.73.

Waters Trading Up 1.1%

Shares of Waters stock traded up $3.26 during trading on Monday, reaching $309.58. 599,435 shares of the company were exchanged, compared to its average volume of 612,621. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $18.43 billion, a price-to-earnings ratio of 27.92, a P/E/G ratio of 2.86 and a beta of 1.07. The business has a 50-day moving average price of $304.79 and a 200-day moving average price of $335.48.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same period in the prior year, the firm posted $2.63 earnings per share. The business's quarterly revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.